Journey Medical Corporation
DERM • NASDAQ
Journey Medical Corporation is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Claude Maraoui, with a market cap of $125.0M.
CEOClaude Maraoui
Market Cap$125.0M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees58.0
Websitejourneymedicalcorp.com
Next Earnings
Upcoming earnings announcement for Journey Medical Corporation
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.07
Revenue Estimate
$16.0M
Earnings History
Past 12 earnings reports for Journey Medical Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.04Est: -$0.05 | +20.0% | $16.1MEst: $18.9M | -15.1% | — |
| Nov 12, 2025 | Q3 2025 | -$0.09Est: -$0.05 | -80.0% | $17.6MEst: $18.4M | -4.1% |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.16Est: -$0.07 | -128.6% | $15.0MEst: $14.8M | +1.3% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.18Est: -$0.24 | +25.0% | $13.1MEst: $11.9M | +10.5% | 10-Q |
| Mar 26, 2025 | Q4 2024 | $0.08Est: -$0.22 | +136.4% | $13.6MEst: $13.9M | -1.9% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.12Est: -$0.15 | +20.0% | $14.6MEst: $14.4M | +1.7% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.17Est: -$0.14 | -21.4% | $14.9MEst: $13.9M | +7.0% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.53Est: -$0.23 | -130.4% | $13.0MEst: $14.1M | -7.6% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.12Est: -$0.08 | -50.0% | $15.3MEst: $15.1M | +1.3% | 10-K |
| Nov 7, 2023 | Q3 2023 | $0.80Est: -$0.15 | +633.3% | $34.5MEst: $16.9M | +104.6% | — |
| Aug 8, 2023 | Q2 2023 | -$0.46Est: -$0.33 | -39.4% | $17.2MEst: $14.8M | +15.9% | 10-Q |
| May 22, 2023 | Q1 2023 | -$0.30Est: -$0.45 | +33.3% | $12.2MEst: $16.2M | -24.5% | 10-Q |